Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Phenomenex and ChromaDex® Announces Collaboration Agreement

Published: Wednesday, October 03, 2012
Last Updated: Wednesday, October 03, 2012
Bookmark and Share
New solutions to be presented at Association of Analytical Communities annual meeting next week.

Phenomenex Inc. and ChromaDex® Corporation have announced a collaboration agreement that will provide solutions to customers with a combination of reference standards, scientifically valid methods and application support.

The collaboration combines Phenomenex’s strengths in analytical HPLC (high-performance liquid chromatography) with ChromaDex’s extensive line of reference standards, which are used for quality control in dietary supplement manufacturing.

The first three new solutions will be presented as scientific posters at the AOAC (Association of Analytical Communities) annual meeting in Las Vegas next week and will be available as technical notes, the first of which can be viewed at www.phenomenex.com/cdpr.

The FDA has increased its scrutiny of the supplement industry in recent years, precipitating a need for faster, more advanced quality control methods.

“The ability to provide a complete package of reference standards and scientifically valid methods strengthens our leadership position and provides a ‘one stop shop’ for our customers,” said Frank Jaksch, CEO and founder of ChromaDex.

Jaksch continued, “The collaboration will deliver tools to help customers meet FDA guidance on cGMP (current good manufacturing practices) for dietary supplements.”

Phenomenex maintains a full-service analytical support laboratory, staffed with application scientists who specialize in method development and customized solutions.

This team will optimize methods for ChromaDex reference standards, based on the most advanced chromatography technology.

This includes working with a variety of sample matrices and will in many cases include the use of Phenomenex’s core-shell particle technology and Kinetex® columns.

“This collaboration is consistent with our strategy of providing the most complete solutions to the customers we serve,” explains Sky Countryman, manager of PhenoLogix and applied technology for Phenomenex. “We look forward to expanding our involvement with the growing dietary supplement market.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Phenomenex Launches Spin-Off Technology Company Neoteryx LLC
Company will be spinning off a biological sampling focused company named Neoteryx LLC.
Saturday, July 19, 2014
Phenomenex Launches Newsletter for Food Chemists
The Dish is a regular newsletter specially written for the food testing industry.
Tuesday, April 15, 2014
Phenomenex Phree™ Phospholipid Removal Plates Win R&D 100 Award
Winners will be recognized at the R&D 100 Awards Banquet on November 7.
Monday, July 15, 2013
Phenomenex CEO Receives the Ellis Island Medal of Honor
Fasha Mahjoor was presented with an Ellis Island Medal of Honor, which ranks among the United States’ most prestigious awards.
Thursday, May 16, 2013
Phenomenex to Host AACC Workshop on LC/MS/MS for Clinical Diagnostics
Two-day, hands-on program to be held May 15 and 16.
Friday, May 10, 2013
Phenomenex Serves Growing Korean Market with Translated Website
Site also introduces a new industry-focused interface to help customers quickly find the best columns and methods for their needs.
Tuesday, May 07, 2013
Phenomenex Expert Selected to Present on Residues and Contaminants in Food
United Nations Agencies Fund Initiative to improve food safety in developing countries.
Wednesday, April 24, 2013
Phenomenex Launches Environmental Edge Newsletter
Environmental Edge newsletter will provide useful information on industry trends and tips.
Monday, April 08, 2013
Phenomenex Launches Innovative, Industry-Focused Websites
Company builds on award-winning web presence with new digital experience.
Friday, February 22, 2013
Phenomenex to Present Four Workshops at Pittcon 2013
Workshops will cover proteins, environmental contaminants, oligonucleotide therapeutics and core-shell technology.
Monday, December 17, 2012
Phenomenex Chiral Screening Services Now Offered in China
Collaboration with Chinese Academy of Sciences ensures fast, high-quality screening.
Wednesday, December 05, 2012
Phenomenex Forms Phenova - A Certified Reference Materials Company
New company culminates the integration and expansion of Colorado-based Wibby Environmental.
Friday, August 24, 2012
Phenomenex Celebrates 30 Years
The company has grown from a one-man operation out of a garage to over 700 employees and a network of partners in 95 countries in only three decades.
Wednesday, June 13, 2012
Phenomenex Announces Direct Sales and Service for Sweden
Company expands its international team to serve Sweden.
Monday, January 30, 2012
Workshops on Biofuels Analysis and New Applications for UHPLC
Phenomenex Inc. will be presenting two workshops at Pittcon 2012 in Orlando.
Monday, January 09, 2012
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!